Back to the main directory
Company Analysis / Equity
- Many Positive Trends Within the Banking Industry, but Compelling Valuations Are Tough to Find by Morningstar
- Many Positive Trends Within the Banking Industry, but Compelling Valuations Are Tough to Find by Morningstar
- Many Positive Trends Within the Banking Industry, but Compelling Valuations Are Tough to Find by Morningstar
- Sands intangibale asset strengthened by a likely Japanese gaming concession. by Morningstar
- Liberty Global closes the merger of its Dutch business with Vodafone's Dutch business. by Morningstar
- Many Positive Trends Within the Banking Industry, but Compelling Valuations Are Tough to Find by Morningstar
- Vivendi increases its stake in Telecom Italia to 24.7%, but don't expect much change. by Morningstar
- TD Bank's continued dominance in Canada should keep excess returns in place. by Morningstar
- Many Positive Trends Within the Banking Industry, but Compelling Valuations Are Tough to Find by Morningstar
- Wipro Says ADR Dates Yet to Be Determined; Industry Outlook Unchanged, Maintaining $10 FVE by Morningstar
- Canadian Pacific Delivers an Excellent 56.7% Operating Ratio on 3% Revenue Growth by Morningstar
- Sun Life’s 2017 2Q Results In Line With Our Long-Term Expectations; Maintaining CAD FVE by Morningstar
- Taking Care Inside the Village Before Venturing Outside by Morningstar
- Meggitt’s 3Q civil aerospace revenue below expectations, but strong military rebound expected in 4Q. by Morningstar
- Banco Santander's franchise remains strong, but slowdowns in local markets weigh on profits. by Morningstar
- Another Strong Quarter in a Difficult Environment for ABI as Premiumisation Thesis Remains Intact by Morningstar
- First Republic is one of the fastest-growing banks we cover. by Morningstar
- Alphabet Reports Another Strong Quarter; Raising FVE to $1,100; Shares Fairly Valued by Morningstar
- Amazon's long-term cash flow profile evolving beyond AWS, Prime, and third-party with Whole Foods. by Morningstar
- Amgen Produces In-Line 3Q; Expect to Slightly Raise Our FVE on Pipeline Progress by Morningstar
- Beyond Revlimid, Celgene's oncology and immunology pipeline support a narrow moat. by Morningstar
- Alliance Automotive acquisition boosts Genuine Parts’ global scale; offers expansion opportunities. by Morningstar
- While publishing deterioration persists, Wiley’s solutions businesses should drive future growth. by Morningstar
- Magna 3Q Results Hit Record High; Maintaining $55/CAD 69 FVE by Morningstar
- Reliance Steel & Aluminum Posts Higher 1Q Sales and Profits; Our $64 FVE Is Unchanged by Morningstar